Navigating global regulatory requirements is complicated. We can help.

USDM Life Sciences has been conducting audits and assessments for the biotech, medical device, and pharmaceutical industries for more than 20 years. Our team of highly qualified auditors employs the FDA’s Quality Systems Inspection Technique auditing approach to ensure that your regulatory requirements are met, and you can demonstrate your Quality System is operating in a state of control.

Our regulatory audits focus on investigating specific systems and processes to ensure they meet regulatory requirements and industry standards. We identify observations and gaps in systems, processes, and documentation. We then verify that processes are documented and being followed, and that GxP records, objective evidence, and data integrity are adequate. USDM audit reports will unveil our findings based on years of unmatched industry expertise and create visibility to where you need to address potential risks.

Audit Services:

  • Software Vendor Qualification Audits
  • Supplier Qualification Audits (CMO, CRO, API, Supply Chain, Distributor)
  • Mock Audits
  • GxP Audits (GCP, GLP, GMP)
  • Pre-Approval Inspection Audits (PAI)
  • Audit readiness
  • Auditing-as-a-Service
  • Drug Accountability Audits
  • Device Quality Audits
  • Internal Audits

We provide single audit services, staffing augmentation to supplement your current audit team, or managed services, (i.e. Auditing-as-a-Service) where we provide a team of auditors to handle all your auditing needs.

Our Assessment services take a more holistic approach to your regulatory requirements. Just like audits, we uncover the gaps and risks to your systems and processes and deliver a report of our findings. During an assessment we may use a variety of techniques to gather pertinent information, based on the needs of your organization. Additionally, we provide a recommendation for how you remediate those findings and prioritize them based on your unique circumstances – your business priorities, your resources available, your technical know-how, and your understanding of the regulation. And if you need us to do the remediation work too, we can help!


Assessment Services:

  • EU MDR Assessment – The deadline of May 26, 2020, is approaching, and you need to be sure your Quality Management System is ready.
  • IT Assessments – We inspect your IT infrastructure, processes, documentation, and roles and responsibilities of your IT team to ensure your technology and technical processes are compliant. 
  • Data Integrity Assessments – Your data is your most valuable IP. Your data must be correct, reproducible, and have controls in place to keep it that way.
  • Quality Management Assessment – Your quality system is the heart of what enables your business to thrive, and you can’t afford to have gaps that jeopardize your compliant state.
  • CSV Assessments – Computer System Validation assessments ensure your systems and applications are GxP compliant. We offer both on-prem and cloud CSV assessments.

Case Studies

Quality System Upgrade to meet EU MDR / IVDR
MDSAP Ready in 4 Months
FDA Mandated Global CSV Remediation

Contact us now to get your questions answered by former FDA auditors at (888) 231-0816.
Or, you can email us your questions.

Audits and Assessments FAQ

  • What is a software vendor audit?

    A software vendor audit in the life sciences industry is an audit of the software companies’ products, services, and processes to ensure the technology aligns with their customer’s regulatory agency requirements. The audit typically reviews the vendor’s quality systems and software development process, including documented evidence such as procedures, tests, and records.

  • Why audit suppliers and vendors?

    Life science companies are required to qualify critical vendors such as drug and component manufacturers and key suppliers. The list also includes software vendors who supply software solutions for critical processes within the drug and medical device manufacturing process. This qualification ensures that the vendors have consistent software and quality processes in place and that they are under a state of control that is satisfactory to the regulated demands of the life sciences industry. USDM’s Cloud Assurance service includes audits for the respective SaaS vendor (i.e. Salesforce, Box, DocuSign, Oracle, etc.).

  • Why should I conduct a mock audit?

    Mock audits are usually performed well in advance of an actual agency or registrar audit. These “test” audits allow companies to self-identify any gaps in their processes and procedures that are audited by the FDA and other regulated agencies. Some of the types of mock audits include PAI (pre-approval inspection) audits, ISO audits, and cGMP audits.

    Here are the top 10 audit failures we see at life science companies.

  • What is 21 CFR Part 11 and GxP auditing?

    Title 21 CFR Part 11 is the part of Title 21 of the Code of Federal Regulations (CFR) that establishes the FDA regulations on electronic records and electronic signatures (ERES). Part 11 is a law that ensures that companies implement good business practices by defining the criteria under which electronic records and signatures are considered to be accurate, authentic, trustworthy, reliable, confidential, and equivalent to paper records and handwritten signatures on paper. The goal of the Part 11 audits is to ensure life sciences companies are implementing the required controls to ensure the safety of users of their products. GxP refers to “good working practices” about various areas of the life sciences industry. They include manufacturing, laboratory, clinical, etc. The audits are conducted against these practices to ensure compliance.

  • How do I prepare for IT audits in medical device, biotech, and pharma companies?

    With 20 years of life sciences experience and former FDA auditors on staff, USDM is the leading consulting firm to help you prepare for audits in the biotech, medical device, and pharmaceutical industries. Our expertise delivers a proficient and efficient process to save you time and money. We provide single audit services, staffing augmentation to supplement your current audit team or managed services (i.e. Auditing-as-a-Service), where we offer a team of auditors to handle all your auditing needs.

    Read a case study on how we helped a customer get MDSAP-ready in 4 months.

  • What is the FDA’s Pre-Approval Inspection (PAI) Program?

    A pre-approval inspection (PAI) is conducted to substantiate to the FDA that a manufacturing facility named in a drug application is capable of manufacturing a drug, and that submitted data are accurate and complete. USDM conducts PAI-readiness audits and mock PAI audits to improve your probability of success.
    Read our white paper on FDA PAI.

Thought Leaders

Leading experts in every Life Sciences field.

Learn More
Bob Lucchesi
Bob Lucchesi

Vice President of Global Regulatory Compliance, Quality Assurance and Auditing

Jay Crowley
Jay Crowley

Vice President of Medical Device Solutions and Services

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.